Promoting fusion in minimally invasive lumbar interbody stabilization with low-dose bone morphogenic protein-2 - But what is the cost?

Spine Journal

Volumn 11, Issue 6, 2011, Pages 527-533

  Mannion, Richard J ^a   Nowitzke, Adrian M ^b   Wood, Martin J ^b,c  

^a CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^b PRINCESS ALEXANDRA HOSPITAL   (Australia)

^c Mater Private Hospital Brisbane   (Australia)

Author keywords

BMP; Complications; Fusion; Minimally invasive

Indexed keywords

RECOMBINANT BONE MORPHOGENETIC PROTEIN 2;

ADULT; AGED; ARTICLE; BONE GRAFT; BONE REMODELING; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; COST; DECOMPRESSION SURGERY; FEMALE; HETEROTOPIC OSSIFICATION; HUMAN; LOW DRUG DOSE; LUMBAR SPINE; MALE; MINIMALLY INVASIVE LUMBAR INTERBODY STABILIZATION; MULTIPLANAR RECONSTRUCTION; OBSERVATIONAL STUDY; OSTEOLYSIS; PEDICLE SCREW; POSTERIOR LUMBAR INTERBODY FUSION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSEUDARTHROSIS; SPINE FUSION; SPINE RADIOGRAPHY; SPINE STABILIZATION; TARLOV CYST; TRANSFORAMINAL LUMBAR INTERBODY FUSION; TREATMENT DURATION; VERTEBRA BODY;

ADULT; AGED; BONE MORPHOGENETIC PROTEIN 2; CYSTS; FEMALE; HUMANS; LUMBAR VERTEBRAE; MALE; MIDDLE AGED; OSSIFICATION, HETEROTOPIC; OSTEOLYSIS; POSTOPERATIVE COMPLICATIONS; RECOMBINANT PROTEINS; SPINAL FUSION; TRANSFORMING GROWTH FACTOR BETA; TREATMENT OUTCOME; YOUNG ADULT;

EID: 79959980181     PISSN: 15299430     EISSN: 18781632     Source Type: Journal    
DOI: 10.1016/j.spinee.2010.07.005     Document Type: Article

References (28)

1. J.D. Schwender, L.T. Holly, D.P. Rouben, and K.T. Foley Minimally invasive transforaminal lumbar interbody fusion (TLIF): technical feasibility and initial results J Spinal Disord Tech 18 Suppl 2005 S1 S6 (Pubitemid 44620794)
2. L.T. Holly, J.D. Schwender, D.P. Rouben, and K.T. Foley Minimally invasive transforaminal lumbar interbody fusion: indications, technique, and complications Neurosurg Focus 20 2006 E6
3. P. Park, and K.T. Foley Minimally invasive transforaminal lumbar interbody fusion with reduction of spondylolisthesis: technique and outcomes after a minimum of 2 years' follow-up Neurosurg Focus 25 2008 E16
4. C. Schizas, N. Tzinieris, E. Tsiridis, and V. Kosmopoulos Minimally invasive versus open transforaminal lumbar interbody fusion: evaluating initial experience Int Orthop 33 2008 1683 1688
5. N.E. Epstein An analysis of noninstrumented posterolateral lumbar fusions performed in predominantly geriatric patients using lamina autograft and beta tricalcium phosphate Spine J 8 2008 882 887
6. A.A. Faundez, J.D. Schwender, and Y. Safriel Clinical and radiological outcome of anterior-posterior fusion versus transforaminal lumbar interbody fusion for symptomatic disc degeneration: a retrospective comparative study of 133 patients Eur Spine J 18 2009 203 211
7. C. Schizas, D. Triantafyllopoulos, V. Kosmopoulos, and K. Stafylas Impact of iliac crest bone graft harvesting on fusion rates and postoperative pain during instrumented posterolateral lumbar fusion Int Orthop 33 2009 187 189
8. P.V. Mummaneni, J. Pan, R.W. Haid, and G.E. Rodts Contribution of recombinant human bone morphogenetic protein-2 to the rapid creation of interbody fusion when used in transforaminal lumbar interbody fusion: a preliminary report. Invited submission from the Joint Section Meeting on Disorders of the Spine and Peripheral Nerves, March 2004 J Neurosurg Spine 1 2004 19 23 (Pubitemid 38812651)
9. P.J. Slosar, R. Josey, and J. Reynolds Accelerating lumbar fusions by combining rhBMP-2 with allograft bone: a prospective analysis of interbody fusion rates and clinical outcomes Spine J 7 2007 301 307 (Pubitemid 46667736)
10. V. Joseph, and Y.R. Rampersaud Heterotopic bone formation with the use of rhBMP2 in posterior minimal access interbody fusion: a CT analysis Spine 32 2007 2885 2890 (Pubitemid 351339361)
11. H.J. Meisel, M. Schnöring, and C. Hohaus Posterior lumbar interbody fusion using rhBMP-2 Eur Spine J 17 2008 1735 1744
12. C. Papakostidis, G. Kontakis, M. Bhandari, and P.V. Giannoudis Efficacy of autologous iliac crest bone graft and bone morphogenetic proteins for posterolateral fusion of lumbar spine: a meta-analysis of the results Spine 33 2008 E680 E692
13. Y. Katayama, Y. Matsuyama, and H. Yoshihara Clinical and radiographic outcomes of posterolateral lumbar spine fusion in humans using recombinant human bone morphogenetic protein-2: an average five-year follow-up study Int Orthop 33 2009 1061 1067
14. D. Benglis, M.Y. Wang, and A.D. Levi A comprehensive review of the safety profile of bone morphogenetic protein in spine surgery Neurosurgery 62 5 Suppl 2 2008 ONS423 ONS431
15. S.A. Mindea, P. Shih, and J.K. Song Recombinant human bone morphogenetic protein-2-induced radiculitis in elective minimally invasive transforaminal lumbar interbody fusions: a series review Spine 34 2009 1480 1484
16. R.W. Molinari, K.H. Bridwell, S.J. Klepps, and C. Baldus Minimum 5-year follow-up of anterior column structural allografts in the thoracic and lumbar spine Spine 24 1999 967 972 (Pubitemid 29222615)
17. J.N. Weinstein, J.D. Lurie, and T.D. Tosteson Surgical compared with nonoperative treatment for lumbar degenerative spondylolisthesis. Four-year results in the Spine Patient Outcomes Research Trial (SPORT) randomized and observational cohorts J Bone Joint Surg Am 91 2009 1295 1304
18. P. Fritzell, O. Hägg, P. Wessberg, A. Nordwall, and Swedish Lumbar Spine Study Group Chronic low back pain and fusion: a comparison of three surgical techniques: a prospective multicenter randomized study from the Swedish lumbar spine study group Spine 27 2002 1131 1141 (Pubitemid 34596329)
19. K.R. Garrison, S. Donell, and J. Ryder Clinical effectiveness and cost-effectiveness of bone morphogenetic proteins in the non-healing of fractures and spinal fusion: a systematic review Health Technol Assess 11 2007 1 150
20. J.K. Burkus, E.E. Transfeldt, and S.H. Kitchel Clinical and radiographic outcomes of anterior lumbar interbody fusion using recombinant human bone morphogenetic protein-2 Spine 27 2002 2396 2408 (Pubitemid 35266228)
21. S.J. Ackerman, M.S. Mafilios, and D.W. Polly Jr. Economic evaluation of bone morphogenetic protein versus autogenous iliac crest bone graft in single-level anterior lumbar fusion: an evidence-based modeling approach Spine 27 16 Suppl 1 2002 S94 S99
22. S.D. Glassman, L.Y. Carreon, and M. Djurasovic RhBMP-2 versus iliac crest bone graft for lumbar spine fusion: a randomized, controlled trial in patients over sixty years of age Spine 33 2008 2843 2849
23. B. McKay, and H.S. Sandhu Use of recombinant human bone morphogenetic protein-2 in spinal fusion applications Spine 27 16 Suppl 1 2002 S66 S85
24. D.A. Wong, A. Kumar, and S. Jatana Neurologic impairment from ectopic bone in the lumbar canal: a potential complication of off-label PLIF/TLIF use of bone morphogenetic protein-2 (BMP-2) Spine J 8 2008 1011 1018
25. N.F. Chen, Z.A. Smith, and E. Stiner Symptomatic ectopic bone formation after off-label use of recombinant human bone morphogenetic protein-2 in transforaminal lumbar interbody fusion J Neurosurg Spine 12 2010 40 46
26. K.U. Lewandrowski, C. Nanson, and R. Calderon Vertebral osteolysis after posterior interbody lumbar fusion with recombinant human bone morphogenetic protein 2: a report of five cases Spine J 7 2007 609 614 (Pubitemid 47471438)
27. R. Vaidya, A. Sethi, and S. Bartol Complications in the use of rhBMP-2 in PEEK cages for interbody spinal fusions J Spinal Disord Tech 21 2008 557 562
28. L.M. Tumialán, and G.E. Rodts Adverse swelling associated with use of rh-BMP-2 in anterior cervical discectomy and fusion Spine J 7 2007 509 510